![Page 1: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/1.jpg)
Roma, 9-11 novembre 2012
![Page 2: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/2.jpg)
Roma, 9-11 novembre 2012
![Page 3: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/3.jpg)
Roma, 9-11 novembre 2012
![Page 4: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/4.jpg)
Roma, 9-11 novembre 2012
![Page 5: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/5.jpg)
Roma, 9-11 novembre 2012
Farmaco in fascia C costo mensile 80€
![Page 6: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/6.jpg)
Roma, 9-11 novembre 2012
Farmaco in fascia C costo mensile 55€
![Page 7: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/7.jpg)
Roma, 9-11 novembre 2012
![Page 8: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/8.jpg)
Roma, 9-11 novembre 2012
Dromos 1500 mg/die
Farmaco in fascia C costo mensile 52€
![Page 9: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/9.jpg)
Roma, 9-11 novembre 2012
Trental 1200 mg/die
Farmaco in fascia C costo mensile 33€
Non in commercio
![Page 10: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/10.jpg)
Roma, 9-11 novembre 2012
![Page 11: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/11.jpg)
Roma, 9-11 novembre 2012
33% DIABETICI
![Page 12: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/12.jpg)
Roma, 9-11 novembre 2012
27% DIABETICI
![Page 13: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/13.jpg)
Roma, 9-11 novembre 2012 LINEE GUIDA NICE
![Page 14: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/14.jpg)
Roma, 9-11 novembre 2012 LINEE GUIDA NICE
![Page 15: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/15.jpg)
Roma, 9-11 novembre 2012
INFUSIONE DI PROSTAGLANDINE NEI PAZIENTI
NON RIVASCOLARIZZABILI
CONCLUSIONI 1
![Page 16: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/16.jpg)
Roma, 9-11 novembre 2012 CONCLUSIONI 2
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases 2011
![Page 17: Roma, 9-11 novembre 2012 · Terapia di prima scelta Linee Guida TASC Il 2007 . 2G.2011 ESC ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Naftidrofurile](https://reader030.vdocuments.net/reader030/viewer/2022013007/5c65fb9d09d3f230488b6f95/html5/thumbnails/17.jpg)
Roma, 9-11 novembre 2012